-
Genomic profiling of Rare Tumors
Study
EGAS00001007103
-
Ghana Prostate Study
Study
phs000838
-
METABRIC
Study
EGAS00000000098
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001003258
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Study
EGAS00001003233
-
Polyomavirus-positive Merkel cell carcinoma derived from a trichoblastoma suggests an epithelial origin of Merkel cell carcinoma
Study
EGAS00001003784
-
Molecular profiling reclassifies adult astroblastoma into known and clinically distinct tumor entities with frequent MAPK pathway alterations
Study
EGAS00001003798
-
Genetic characterization of a Unique Neuroendocrine Transdifferentiation Prostate Circulating Tumor Cell - Derived eXplant (CDX) Model
Study
EGAS00001004272
-
Molecular analysis of CRC in patients with Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD)
Study
EGAS00001004497
-
Single cell sequencing of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Study
EGAS00001002845
-
DNA methylation and Panel sequencing for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs)
Study
EGAS00001005731
-
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids induces a carcinoma-like genotype
Study
EGAS00001005949
-
Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial
Study
EGAS00001006905
-
Enhancer profiling to identify identifies epigenetic markers of endocrine resistance in metastatic castration resistant prostate cancer patients
Study
EGAS00001006161
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
Identifying_Novel_Fusion_Genes_in_Myeloma
Study
EGAS00001000220
-
Bisulphite_MPN_colonies
Study
EGAS00001003094
-
Characterization_of_individual_foci_of_multicentric_multifocal_breast_cancer_using_targeted_next_generation_sequencing
Study
EGAS00001000407
-
Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma
Study
EGAS00001004430
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
Genomic Signatures Define Three Subtypes of EGFR-Mutant Stage II-III NSCLC With Distinct Adjuvant Therapy Outcomes
Study
EGAS00001005632
-
Anti-Cancer Therapies Induce Mutations in Adult Stem Cells in a Tissue-Specific Manner
Study
EGAS00001006042
-
ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
Study
EGAS00001006268
-
BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
Study
EGAS00001007465
-
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC (Hipo_015)
Study
EGAS00001007143
-
Xenograft_Sequencing
Study
EGAS00001000140
-
Cross-site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms of CIMAC-CIDC Network
Study
phs002295
-
Genome-wide DNA methylation profiles of NSCLC xenograft and primary lung tissues for the identification of epigenetic predictive biomarkers.
Study
EGAS00001002479
-
A dataset compiled as a resource a for orthogonal assessment of exon CNV calling in NGS data
Study
EGAS00001002428
-
Prostate Cancer Upgrading Reference Set
Study
phs003670
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
Defining the metastasome in colorectal cancer: Implications for hypotheses on metastasis evolution and personalized therapy (HIPO-032)
Study
EGAS00001002717
-
National Cancer Institute Cancer Genome Characterization Initiative (CGCI)
Study
phs000235
-
Time series analysis of neoadjuvant chemotherapy and bevacizumab treated breast carcinomas reveals a systemic shift in genomic aberrations
Study
EGAS00001003287
-
IMPRESS: Improved Methylation Profiling using Restriction Enzymes and smMIP Sequencing, Combined with New Biomarker Panel, Creating Multi-Cancer Detection Assay
Study
EGAS00001007559
-
Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment
Study
EGAS00001000337
-
Characterization of T cell tumor infiltration in brain metastases through the analysis of the cerebrospinal fluid
Study
EGAS00001004751
-
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Study
EGAS00001005791
-
Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Study
EGAS00001006342
-
Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient
Study
EGAS00001006530
-
Evolution_of_the_cancer_epigenome_in_myeloproliferative_neoplasms_2
Study
EGAS00001002372
-
Kings_Hepatoblastoma_Behjati_RNA_Managed_Access
Study
EGAS00001006876
-
Genetic Predictors of Adverse Radiotherapy Effects (Gene-PARE)
Study
phs000772
-
Genomic Sequencing of Cervical Cancers
Study
phs000600
-
Whole-Genome sequencing of hepatocellular carcinomas
Study
EGAS00001000706
-
Integrated genomic analysis for HCC
Study
EGAS00001007957